** The Univer-cell Alchemist: Dr Subhadra Dravida’s breakthrough research on novel stem cell treatment for Covid patients

Bio-entrepreneur Dr Subhadra Dravida is inspired by Paulo Coelho.

Her favourite line is from The Alchemist “When you seek something, all the Universe conspires in helping you to achieve it.” Says the scientist and owner of healthcare startup Transcell Oncologics,

“Since the news of the virus erupted in March 2020, I had been thinking on these lines. And in three months it happened. If everything goes well, our solution will actually get implemented in a month or two in India.”

The Universe did step in and Dravida is the new medical star whose breakthrough research on a novel stem cell treatment holds promise for Covid patients.  

Hyderabad

** Drug 2-DG will work wonders in fighting coronavirus, says Ex-CCMB director Rakesh Mishra

Former Director of Centre for Cellular and Molecular Biology (CCMB), Dr Rakesh Mishra, said that 2-deoxy-D-glucose (2-DG) drug would do wonders in fighting against mild and severe Covid-19 cases.

This anti Covid-19 drug developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), a Defence Research and Development Organisation along with Dr Reddy’s Laboratories, with the help of CCMB has been approved by the Drug Controller General of India.

** India topped 2020 vehicle imports into South Africa despite COVID-19 impact: Report

India was the top country of origin for vehicle imports into South Africa despite the lengthy COVID-19 lockdowns and overall declines in vehicle sales in 2020, according to the latest 2021 auto report.

The Automotive Export Manual report released here on Friday by the Automotive Industry Export Council said that India has been established by several global brands as a production hub for entry-level and small vehicles, and most of the vehicles imported from India fell into these categories.

Volkswagen’s Polo Vivo was the only vehicle in these segments that was manufactured locally in South Africa in 2020.

** Imports of oxygen concentrators, supplies from China surge

Most of the supplies coming in from China have been imported by private Indian companies on a commercial basis.

Chinese companies manufacturing oxygen concentrators and other medical supplies are reporting a record surge in orders for April and May from Indian companies amid the current wave of COVID-19 cases and shortages in supplies.

Since April, orders for at least 40,000 oxygen concentrators have been placed by Indian companies, of which 21,000 have so far been delivered, along with more than 5,000 ventilators, 21 million face masks and 3,800 tons of medicines, according to official Chinese customs figures

** Natco gets CDSCO nod for emergency use of Baricitinib tablets for COVID-19 treatment

Baricitinib in combination with Remdesivir, is used for treatment of COVID-19 positive patients, the Natco Pharma said

Drugmaker Natco Pharma has received emergency use approval for Baricitinib tablets, 1 mg, 2 mg and 4 mg strengths, from Central Drugs Standard Control Organisation (CDSCO) in India. 

Baricitinib, in combination with Remdesivir, is used for treatment of COVID-19 positive patients, a release from Natco on the approval said. 

** Reliance Retail 2nd fastest growing retailer in world

The top 10 has seven US retailers and one from the UK (Tesco PLC at 10th position).

Billionaire Mukesh Ambani’s Reliance Retail Ltd has been ranked second fastest growing retailer in the world in the 2021 ranking of global retail power houses by Deloitte, down from top rank secured the previous years.

It has been ranked 53rd in the list of Global Powers of Retailing, improvement from 56th earlier, according to the Deloitte report.

** Texas Instruments to set up 86 ICU beds

Texas Instruments on Saturday announced setting up of 86 critical care beds in a modular ICU unit at the Rajiv Gandhi Institute of Chest Diseases in Bengaluru.

Given as part of the Corporate Social Responsibility (CSR) initiative, the ICU unit will come up at an investment of Rs 3 crore and will be ready in 3-4 weeks.

** Indian biotech startup claims breakthrough in early-stage cancer detection

Tzar Labs, a molecular diagnostic company in coordination with the Mumbai-based Epigeneres Biotechnology, has claimed to have developed a breakthrough blood test for early prognosis/diagnosis of cancer.